Gene · 3802
Papers2,190
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,190
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between decidual natural killer cells and extravillous trophoblasts at the maternal-fetal interface: current status and future perspectives. | Front Immunol | 2025 | 41200190 | PubTator, text mining | PubMed |
| Selective agonists of KIR and NKG2A to evade missing self response of natural killer cells. | Sci Rep | 2025 | 41023081 | PubTator, text mining | PubMed |
| EBV Infection Alters NK Cell Phenotype Distinctly From hCMV. | J Med Virol | 2025 | 41002189 | PubTator, text mining | PubMed |
| Allele Level Sequencing of Killer Cell Immunoglobulin-Like Receptor Genes Using Oxford Nanopore Long Read Sequencing. | HLA | 2025 | 40985045 | PubTator, text mining | PubMed |
| Expression of metabolic genes in NK cells is associated with clinical outcomes in patients with severe COVID-19: a brief report. | Front Cell Infect Microbiol | 2025 | 40927375 | PubTator, text mining | PubMed |
| T cell exhaustion‑related gene CD79B predicts prognosis, inhibits malignant progression and promotes tumor‑associated macrophage M1‑like polarization in lung adenocarcinoma. | Oncol Rep | 2025 | 40878933 | PubTator, text mining | PubMed |
| PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immune-checkpoint blockade. | J Exp Clin Cancer Res | 2025 | 40877861 | PubTator, text mining | PubMed |
| Profiling associations of interactive ligand-receptors (HLA class I and KIR gene products) with the progression to type 1 diabetes among seroconverted participants. | Diabetologia | 2025 | 40835749 | PubTator, text mining | PubMed |
| Comprehensive bioinformatics analysis of EXOSC family genes in head and neck squamous cell carcinoma. | Sci Rep | 2025 | 40830179 | PubTator, text mining | PubMed |
| A comprehensive analysis of the tryptophan metabolism-related gene signature to predict the prognosis of esophageal squamous cell carcinoma based on multi-omics. | Front Mol Biosci | 2025 | 40821701 | PubTator, text mining | PubMed |
| Exploring the prognostic value and immune landscape of EGLN1 in colorectal cancer: insights from bioinformatics analysis. | Discov Oncol | 2025 | 40753313 | PubTator, text mining | PubMed |
| NK Alloreactivity Evaluation According to KIR-HLA Interaction Models Influences the Outcome of Haploidentical Haematopoietic Stem-Cell Transplantation Based on Post-Transplant Cyclophosphamide. | HLA | 2025 | 40747880 | PubTator, text mining | PubMed |
| Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell Responses. | J Clin Immunol | 2025 | 40728766 | PubTator, text mining | PubMed |
| RIFINs displayed on malaria-infected erythrocytes bind KIR2DL1 and KIR2DS1. | Nature | 2025 | 40500441 | PubTator, text mining | PubMed |
| The Impact of Killer Cell Immunoglobulin-Like Receptors and Human Leukocyte Antigen-E, Human Leukocyte Antigen-G Polymorphisms on Innate Immunity and COVID-19 Severity. | J Immunol Res | 2025 | 40391199 | PubTator, text mining | PubMed |
| Study on γδT-Cell Degranulation at Maternal-Fetal Interface via iKIR-HLA-C Axis. | Cells | 2025 | 40358173 | PubTator, text mining | PubMed |
| Spatial statistics of submicron size clusters of activating and inhibitory Natural Killer cell receptors in the resting state regulate early time signal discrimination. | bioRxiv | 2025 | 40196617 | PubTator, text mining | PubMed |
| HLA-A*03 may confer protection against long COVID through an enhanced immune response. | Infect Dis Now | 2025 | 40107360 | PubTator, text mining | PubMed |
| Association of killer cell immunoglobulin-like receptor genes with primary Sjögren's syndrome among Chinese population. | Hum Immunol | 2025 | 39947039 | PubTator, text mining | PubMed |
| Isolation and characterization of primary NK cells and the enrichment of the KIR2DL1+ population. | Methods Cell Biol | 2025 | 39919843 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3802/papers?page=2